Smithfield Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$123K Sell
1,429
-23
-2% -$2.2K 0.01% 449
2025
Q4
$139K Buy
1,452
+258
+22% +$25.1K 0.01% 421
2025
Q3
$113K Hold
1,194
0.01% 443
2025
Q2
$103K Hold
1,194
﹤0.01% 442
2025
Q1
$109K Sell
1,194
-179
-13% -$16K 0.01% 423
2024
Q4
$110K Sell
1,373
-32
-2% -$2.77K 0.01% 426
2024
Q3
$129K Buy
1,405
+29
+2% +$2.44K 0.01% 413
2024
Q2
$108K Sell
1,376
-114
-8% -$9.35K 0.01% 427
2024
Q1
$129K Buy
1,490
+10
+0.7% +$853 0.01% 408
2023
Q4
$122K Sell
1,480
-300
-17% -$22.9K 0.01% 395
2023
Q3
$138K Sell
1,780
-246
-12% -$20.6K 0.01% 358
2023
Q2
$178K Sell
2,026
-212
-9% -$18.3K 0.01% 329
2023
Q1
$179K Sell
2,238
-2,059
-48% -$168K 0.01% 313
2022
Q4
$335K Sell
4,297
-1,392
-24% -$113K 0.02% 220
2022
Q3
$458K Buy
5,689
+67
+1% +$6.02K 0.03% 178
2022
Q2
$502K Sell
5,622
-504
-8% -$51.1K 0.04% 170
2022
Q1
$681K Sell
6,126
-212
-3% -$22.4K 0.04% 159
2021
Q4
$654K Sell
6,338
-72
-1% -$8.34K 0.04% 166
2021
Q3
$809K Sell
6,410
-81
-1% -$10.5K 0.05% 146
2021
Q2
$806K Sell
6,491
-1,016
-14% -$128K 0.05% 148
2021
Q1
$887K Sell
7,507
-422
-5% -$49.5K 0.06% 139
2020
Q4
$928K Sell
7,929
-241
-3% -$26.5K 0.07% 132
2020
Q3
$849K Sell
8,170
-471
-5% -$47.3K 0.07% 127
2020
Q2
$793K Buy
8,641
+538
+7% +$51.6K 0.07% 125
2020
Q1
$731K Buy
8,103
+358
+5% +$38.1K 0.08% 121
2019
Q4
$879K Sell
7,745
-109
-1% -$12K 0.08% 121
2019
Q3
$853K Buy
7,854
+179
+2% +$18.7K 0.08% 119
2019
Q2
$747K Sell
7,675
-104
-1% -$9.49K 0.08% 125
2019
Q1
$709K Sell
7,779
-1,054
-12% -$94.3K 0.08% 128
2018
Q4
$803K Hold
8,833
0.09% 107
2018
Q3
$869K Hold
8,833
0.09% 112
2018
Q2
$756K Sell
8,833
-120
-1% -$10K 0.09% 120
2018
Q1
$718K Buy
8,953
+380
+4% +$31.3K 0.09% 122
2017
Q4
$692K Buy
8,573
+573
+7% +$45.9K 0.08% 131
2017
Q3
$622K Sell
8,000
-150
-2% -$12.5K 0.08% 135
2017
Q2
$723K Hold
8,150
0.11% 119
2017
Q1
$657K Sell
8,150
-1,666
-17% -$130K 0.1% 126
2016
Q4
$699K Sell
9,816
-100
-1% -$7.86K 0.12% 115
2016
Q3
$857K Sell
9,916
-55
-0.6% -$4.79K 0.15% 89
2016
Q2
$865K Buy
9,971
+45
+0.5% +$3.64K 0.16% 88
2016
Q1
$744K Buy
9,926
+317
+3% +$23.9K 0.14% 98
2015
Q4
$739K Sell
9,609
-258
-3% -$19.4K 0.15% 94
2015
Q3
$660K Sell
9,867
-563
-5% -$41.5K 0.14% 108
2015
Q2
$773K Sell
10,430
-80
-0.8% -$6.11K 0.15% 96
2015
Q1
$820K Buy
10,510
+1,619
+18% +$123K 0.16% 95
2014
Q4
$642K Sell
8,891
-2,936
-25% -$204K 0.13% 117
2014
Q3
$733K Sell
11,827
-110
-0.9% -$6.99K 0.15% 113
2014
Q2
$761K Sell
11,937
-4
-0% -$243 0.15% 115
2014
Q1
$734K Sell
11,941
-107
-0.9% -$6.23K 0.15% 122
2013
Q4
$691K Sell
12,048
-4
-0% -$227 0.14% 128
2013
Q3
$641K Sell
12,052
-452
-4% -$24.3K 0.15% 117
2013
Q2
$644K Buy
+12,504
New +$618K 0.15% 114

Other funds holding MDT

Smithfield Trust's MDT Position: Q1 2026 in Review

Smithfield Trust reduced its Medtronic (MDT) stake by 1.6% in Q1 2026, selling an estimated $2.2K and leaving 1,429 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #449.

Smithfield Trust first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $928K in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Smithfield Trust held 1,429 shares of Medtronic worth $123K as of Q1 2026.
  • Smithfield Trust sold 23 Medtronic shares in Q1 2026, an estimated $2.2K.
  • Medtronic made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #449 holding.
  • Smithfield Trust first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Smithfield Trust's Medtronic position peaked at $928K in Q4 2020.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.